First report of ectopic ACTH syndrome and PTHrP-induced hypercalcemia due to a hepatoblastoma in a child

European Journal of Endocrinology

Volumn 162, Issue 4, 2010, Pages 813-818

  Grunewald, Thomas G P ^a,b   Von Luettichau, Irene ^a   Welsch, Ulrich ^c   Helmuth Günther, Dörr ^d   Höpner, Frank ^e   Kovacs, Kalman ^f   Burdach, Stefan ^a,b   Rabl, Wolfgang ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e Klinikum Schwabing   (Germany)

^f ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CALCIUM; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DOXORUBICIN; ETOPOSIDE; GLUCOSE; IFOSFAMIDE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHORUS;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ARTICLE; BLOOD CHEMISTRY; CALCIUM BLOOD LEVEL; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; ECTOPIC CORTICOTROPIN PRODUCTION; ELECTRON MICROSCOPY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; PARANEOPLASTIC SYNDROME; PHENOTYPE; PHOSPHATE METABOLISM; POLLAKISURIA; POLYURIA; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ACTH SYNDROME, ECTOPIC; CHILD; FEMALE; HEPATOBLASTOMA; HUMANS; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; PARATHYROID HORMONE-RELATED PROTEIN;

EID: 77950331710     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0961     Document Type: Article

References (30)

1. Thirkill CE. Immune-mediated paraneoplasia. British Journal of Biomedical Science 2006 63 185-195.
2. DeLellis RA & Xia L. Paraneoplastic endocrine syndromes: a review. Endocrine Pathology 2003 14 303-317.
3. Beach R, Betts P, Radford M & Millward-Sadler H. Production of human chorionic gonadotrophin by a hepatoblastoma resulting in precocious puberty. Journal of Clinical Pathology 1984 37 734-737.
4. Perilongo G, Rigon F & Murgia A. Oncologic causes of precocious puberty. Pediatric Hematology and Oncology 1989 6 331-340.
5. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA & Nieman LK. Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. Journal of Clinical Endocrinology and Metabolism 2005 90 4955-4962.
6. Newell-Price J, Trainer P, Besser M & Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrine Reviews 1998 19 647-672.
7. Kracht J. Adrenal pathology of Cushing's syndrome in children and juveniles (author's transl). Verhandlungen der Deutschen Gesellschaft für Pathologie 1971 55 142-146.
8. Omenn GS. Ectopic hormone syndromes associated with tumors in childhood. Pediatrics 1971 47 613-622.
9. McKay C & Furman WL. Hypercalcemia complicating childhood malignancies. Cancer 1993 72 256-260.
10. Suva LJ,Winslow GA,Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H & Chen EY. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987 237 893-896.
11. Kemp BE, Moseley JM, Rodda CP, Ebeling PR, Wettenhall RE, Stapleton D, Diefenbach-Jagger H, Ure F, Michelangeli VP & Simmons HA. Parathyroid hormone-related protein of malignancy: active synthetic fragments. Science 1987 238 1568-1570.
12. Ralston SH. The pathogenesis of humoral hypercalcaemia of malignancy. Lancet 1987 2 1443-1446.
13. Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Ocana A, Bisello A, Hollis BW, Rosen CJ,Wysolmerski JJ, Dann P, Gundberg C & Stewart AF. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. Journal of Bone and Mineral Research 2005 20 1792-1803.
14. Schmidt D, Harms D & Lang W. Primary malignant hepatic tumours in childhood. Virchows Archiv. A, Pathological Anatomy and Histopathology 1985 407 387-405.
15. De Ioris M, Brugieres L, Zimmermann A, Keeling J, Brock P, Maibach R, Pritchard J, Shafford L, Zsiros J, Czaudzerna P & Perilongo G. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. European Journal of Cancer 2008 44 545-550.
16. Zimmermann A. The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis. European Journal of Cancer 2005 41 1503-1514.
17. Cairo S, Armengol C, De Reynies A, Wei Y, Thomas E, Renard CA, Goga A, Balakrishnan A, Semeraro M, Gresh L, Pontoglio M, Strick-Marchand H, Levillayer F, Nouet Y, Rickman D, Gauthier F, Branchereau S, Brugieres L, Laithier V, Bouvier R, Boman F, Basso G, Michiels JF, Hofman P, Arbez-Gindre F, Jouan H, Rousselet- Chapeau MC, Berrebi D, Marcellin L, Plenat F, Zachar D, JoubertM, Selves J, Pasquier D, Bioulac-Sage P, Grotzer M, Childs M, FabreM& Buendia MA. Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 2008 14 471-484.
18. Sell S & Leffert HL. Liver cancer stem cells. Journal of Clinical Oncology 2008 26 2800-2805.
19. Glinsky GV. Death-from-cancer signatures and stem cell contribution to metastatic cancer. Cell Cycle 2005 4 1171-1175.
20. Sell S. Cellular origin of cancer: dedifferentiation or stem cell maturation arrest? Environmental Health Perspectives 1993 101 15-26.
21. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T & Thorgeirsson SS. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nature Medicine 2006 12 410-416.
22. Libbrecht L. Hepatic progenitor cells in human liver tumor development. World Journal of Gastroenterology 2006 12 6261-6265.
23. Burdach S, Plehm S, Unland R, Dirksen U, Borkhardt A, Staege MS, Muller-Tidow C & Richter GH. Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2. Cell Cycle 2009 8 1991-1996.
24. Richter GH, Plehm S, Fasan A, Rossler S, Unland R, Bennani- Baiti IM, Hotfilder M, Lowel D, von Luettichau I, Mossbrugger I, Quintanilla-Martinez L, Kovar H, Staege MS, Muller-Tidow C & Burdach S. EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation. PNAS 2009 106 5324-5329.
25. Morrison SJ & Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006 441 1068-1074.
26. Zaret KS & Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008 322 1490-1494.
27. Styne DM, Isaac R, Miller WL, Leisti S, Connors M, Conte FA & Grumbach MM. Endocrine, histological, and biochemical studies of adrenocorticotropin-producing islet cell carcinoma of the pancreas in childhood with characterization of proopiomelanocortin. Journal of Clinical Endocrinology and Metabolism 1983 57 723-731.
28. Kagalwala MN, Singh SK & Majumder S. Stemness is only a state of the cell. Cold Spring Harbor Symposia on Quantitative Biology 2008 73 227-234.
29. Burdach S. Epigenetic Maintenance of Stemness in Pediatric Malignancy. Société Internationale d'Oncologie Pédiatrique (SIOP) Educational Booklet, 2009.
30. Homoki J, Holl R & Teller WM. Urinary steroid profile in Cushing syndrome and in tumors of the adrenal cortex. Klinische Wochenschrift 1987 65 719-726.